- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pfizer Covid vaccine shows favourable safety profile, says USFDA
New York: Raising hope of granting emergency use authorisation to drugmakers Pfizer and BioNTech's experimental Covid-19 vaccine, the US Food and Drug Administration (FDA) said on Tuesday that data from 38,000 trial participants involved in testing the vaccine suggest a "favourable safety profile".
The data on the vaccine showed no "specific safety concerns," the FDA said in a document.
The report comes two days before a group of experts from FDA meet to discuss an emergency use authorisation request for a Covid-19 vaccine.
Pfizer and BioNTech submitted a request for emergency use authorisation of its investigational Covid-19 vaccine to US FDA on November 20.
"As such, FDA has determined that the sponsor has provided adequate information to ensure the vaccine's quality and consistency for authorization of the product under an EUA (Emergency Use Authorisation)," the agency wrote in documents posted.
Read also: Pfizer seeks DCGI emergency use authorisation for COVID vaccine in India
Britain has already approved the vaccine for emergency use.
A 90-year-old woman named Margaret Keenan on Tuesday became the first person in the world to receive the Pfizer-BioNTech Covid-19 vaccine as part of the mass vaccination programme being rolled out across the UK.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.